Objective: Ventricular pacing or arrhythmias can induce cardiac memory (CM). We hypothesized that clinically administered antiarrhythmic drugs alter the expression of CM, and that the repolarization changes characteristic of CM can modulate the effects of antiarrhythmic drugs. Methods: We studied conscious, chronically-instrumented dogs paced for two 1-h periods to study the effects of drugs on the evolution of memory (protocol 1) or for 21 days (protocol 2) to observe the effects of steady-state memory on drug actions. Dogs were treated in both settings with quinidine, lidocaine or E4031, in random order, and within therapeutic serum concentration ranges. Results: Pacing, alone, for 2 h significantly prolonged ERP only near the left ventricular pacing site, whereas pacing alone for 21 days prolonged ERP at all sites (P,0.05). Quinidine and E4031, but not lidocaine, prolonged repolarization and ERP and suppressed evolution of CM in protocol 1. However, quinidine's effect in prolonging repolarization was diminished in both protocols, while its effect in prolonging ERP was diminished in the 21-day protocol only. In contrast, the effects of E4031 were additive to those of CM, prolonging repolarization and ERP in both protocols, while lidocaine showed no changes in effect at all. Conclusions: Pacing to induce CM significantly affects ventricular repolarization and refractoriness, and there are interactions between CM, quinidine and E4031. Depending on the specific drug, these interactions have the potential to be anti-or proarrhythmic, and may impact importantly on the clinical efficacy of drugs as well as on electrophysiologic testing of drug actions.
Introduction
tability have been identified, including variations in drug metabolism and plasma levels, use-dependent and reverse Antiarrhythmic agents often manifest inconsistent antiaruse-dependent actions of individual drugs, and progression rhythmic and proarrhythmic effects in individual patients in the primary diseases that underlie the arrhythmia [1] . and groups of patients during acute or chronic drug Although these determinants of unpredictability are administration [1] . Moreover, inconsistency in drug reimportant, each can to some extent be anticipated and / or sponse has reduced confidence in the utility of procorrected for in treating individual patients. Yet, additional grammed electrical stimulation to predict subsequent clinimechanisms might contribute to the unpredictability of cal benefit. A variety of explanations for this unpredicdrug effect. One such mechanism is the effect of ventricular arrhythmias to induce cardiac memory, defined as a T wave change occurring during sinus rhythm that tracks the [4] and possibly other ion channels [5, 6] , and with an trodes were sewn to the epicardium of (i) the left atrial altered voltage-time course of repolarization in ventricular appendage (LAA), (ii) the right ventricular (RV) free wall, myocardial cells [7] . It is suppressed by blocking I in and (iii) the anterobasal, (iv) apical and (v) inferior LV.
to anesthetized dogs [8] .
These were used to pace or to measure activation-recovery It is also recognized that the binding to and unbinding of intervals (ARI) as previously described [12] . The postdrugs from ion channels is importantly influenced by erolateral electrode was located |2 cm from the pacemaker channel state (open, inactivated and resting), and that the lead. The animals recovered for 2-3 weeks, during which function of ion channels is closely related to the voltagethe ECG stabilized and they were laboratory trained. time course of repolarization [1, 9] . Based on the above, Experiments were performed on conscious animals and because of the altered voltage-time course of repolariresting quietly on the right side. A pseudo-orthogonal zation in cardiac memory, we have hypothesized that three-lead ECG (I, aVF, v10) and the epicardial elecantiarrhythmic drugs may alter the evolution of memory, trogram recordings were acquired at a 1000-Hz sampling and that the electrophysiologic changes accompanying rate using Ponemah software (Gould Instrument Systems) cardiac memory may modify the expression of drug effect and the Dr Vetter PC-EKG program [7] . Frontal plane on ventricular repolarization and refractoriness.
vector images were plotted with the Dr Vetter PC-EKG program.
For each experimental time point, three to five consecu-2. Methods tive cycles of the three pseudo-orthogonal ECG leads were averaged, and the first derivative of the QRST complex All studies were performed on chronically instrumented, was plotted. Time between maximal deflections of the conscious dogs using protocols approved by the Columbia derivative at the beginning (positive) and end (negative) of University Institutional Animal Care and Use Committee.
the QRST complex were considered to define the QT We studied the effects of antiarrhythmic drugs adminisinterval. ERP were measured by stimulating each epicartered to maintain a narrow range of plasma concentrations dial site separately using a nine-beat train of S1 (2-ms on evolution of cardiac memory using a protocol incorduration, 23 threshold amplitude) at BCL5500 ms. Diasporating 2 h of ventricular pacing (referred to as protocol tole was scanned with the ninth beat after which there was 1). As will be shown in Fig. 2 , this protocol produces a pause of 3 min before the next train. The longest S1-S2 non-steady states of memory and of repolarization interval failing to propagate defined the ERP. ERP/ARI changes. This protocol was also considered a surrogate for relationships were calculated as indicators of alteration in changes in drug-cardiac interactions that might occur antiarrhythmic effects. during arrhythmias of recent onset and / or during proCardiac memory was quantified as a function of amgrammed electrical stimulation.
plitude and angle changes of the T wave vector and To study the actions of cardiac memory on the elecexpressed as displacement (in mV) between frontal plane T trophysiologic manifestation of drug effects, we performed vector peaks during atrial pacing at baseline and after 21 days of pacing (referred to as protocol 2). This protocol memory induction (Fig. 1) . To test whether frontal plane provides a steady state of memory and of repolarization recordings gave the same information as those from xy and changes [7] . It was also considered a surrogate for z planes we made simultaneous frontal plane (Dr. Vetter pharmacologic intervention in the setting of a chronic PC-EKG system) and xyz loop recordings (MIDA 1000, cardiac arrhythmia.
Ortivus Medical Systems, Sweden) in five dogs over 21 We studied two highly selective drugs: lidocaine which days. Vector quantification was identical in both systems. blocks fast inward and plateau sodium currents [1, 9] , and E4031, which blocks the rapidly activating component of 2.2. Protocol 1: 2 h of pacing to study evolution of the delayed rectifier potassium current, I [10, 11] . We also cardiac memory Kr studied quinidine, whose actions to block I are accom-K 1 panied by blockade of fast inward Na current, inward A total of five animals were equilibrated during atrial 21 Ca current, and I [1]. pacing (the sinus rhythm surrogate) at CL5500 ms for 15 to min. ECG, electrograms and ERP were recorded and a 2.1. Surgical preparation control blood sample drawn. Then, drug or placebo infusion was started (see below) and atrial pacing was A total of seven dogs weighing 25-30 kg were prepared continued for 30 min. Electrophysiologic measurements as previously described [7] . Under anesthesia and using were repeated and another blood sample was taken. Then, sterile techniques, a unipolar pacing lead (Medtronic to induce cardiac memory, a 60-min period of pacing from model 6917) was attached to the posterolateral left venthe posterolateral LV lead at CL5400 ms was performed, tricular (LV) epicardium. The lead was connected to a followed by 20 min of atrial pacing at CL5500 ms programmable pacemaker (MINIX 8340, Medtronic), (recovery 1; Fig. 2 , horizontal axis). A second ventricular placed in a subcutaneous pocket. Platinum bipolar elecpacing period was followed by a second 20 min of atrial different days as above. On the day each drug was investigated, pacing was discontinued for |4 h to permit performance of the study. As we have shown previously [7] , memory does not decline over such brief periods. To maintain memory at a constant level [4, 7] , on days between drug studies pacing was continued for 23 of each 24 h until all drugs had been studied.
No parallel study of a group of animals instrumented and not paced was performed as a control. However, in an earlier study [7] we incorporated a group of dogs paced from the atrium in a manner comparable to the ventricular pacing used to induce cardiac memory. In this group, no significant change in the ECG and VCG was seen over the time course of the study.
Drug administration
Quinidine was purchased from Sigma (St. Louis, MO) and lidocaine from Schein Pharmaceuticals (Florham Park, NJ). E4031 was a gift from Helopharm-W.Petrik (Berlin, Germany). Vehicle and placebo control was 0.9% NaCl (Baxter Healthcare, Deerfield, IL). Intravenous drug administration schemes were derived from the literature [12] [13] [14] and adjusted to produce stable ECG effects without significant side-effects. For quinidine we administered a 2-mg / kg bolus followed by a 0.07-mg / kg per min infusion. For E4031, the bolus was 50 mg / kg and the infusion 5 mg / kg per min. For lidocaine the bolus was 5 mg / kg and the infusion 0.2 mg / kg per min. After each experiment, serum was separated and stored vectors of a control T wave (T control) and a T wave in the setting of at 2208C until assayed. Drug levels were determined by cardiac memory (T memory). The angle of the T wave vector change in HPLC after extraction [12] . HPLC solvents were purdegrees is measured between lines drawn from the 0 point to the peaks of chased from Burdick and Jackson and other solvents and the two vector loops. Amplitude change is the difference (mV) between chemicals from Fisher Scientific. Quinidine was assayed the peak of the control and the memory T wave vector irrespective of angle. Displacement is the distance (mV) between control and memory T using quinine as the internal standard [12] . E-4031 was wave vectors. quantified per Hashimoto et al. [13] 
. At the end of the second recovery sulfonamide dihydrochloride (Wako) as the internal stanperiod (during which significant memory persisted), elecdard. Lidocaine levels were quantified using the modified trophysiologic parameters were measured and another method of Angelo et al. [15] , with disopyramide as the blood sample drawn. A second placebo infusioninternal standard. performed after protocol 1 was complete -demonstrated a complete return to control conditions. 2.5. Statistics 2.3. Protocol 2: 21 days of pacing to induce steadyData were analyzed using two-way repeated measures state cardiac memory ANOVA to estimate drug and memory effects and their interaction. Subsequent analysis was done using the Bon-A total of three dogs from the 2-h protocol were studied ferroni test where variances were equal and Games-Howell as well as two additional dogs. Drugs were administered where variances were unequal. When analyzing influence and blood samples collected before and after 3 weeks of of only one factor on a dependent variable, we used LV pacing at CL5500 ms (mode VOO; amplitude 3.3-5.0 one-way repeated measures ANOVA. For control values in V; pulse width 0.35-0.5 mV). Electrophysiologic measureall studies, n510 (five dogs in two sets of drug studies, ments were made during LV and atrial pacing at CL5500 with two different control values). For drug groups n55 ms on days 0, 7, 14 and 21. On day 21, electrophysiologic except for quinidine in long-term memory where n54 (in measurements were made and the chronic pacing disone dog serum quinidine level increased to 9 mg / ml. continued. Drugs were infused in random sequence on Although this animal is not included in the overall group, its experimental result was identical). Data are presented as and whether the drugs administered altered this process. mean6S.E.M. P,0.05 was considered significant.
The time courses of cardiac memory accumulation and dissipation in drug-free controls are shown in Fig. 2A . In the drug-free, control state there was T vector displacement 3. Results from baseline, which decayed during recovery 1. The second pacing period led to greater T vector displacement 3.1. Drug concentrations and greater accumulation (i.e. at any time during recovery 2, the extent of displacement was greater than in recovery Serum quinidine levels (mg / ml) were 2.160.4 and 1). This accumulation of T wave changes typifies cardiac 3.060.4, respectively, before and after ventricular pacing memory [3, 7] . Both E4031 and quinidine markedly supin protocol 1, and 2.060.3 and 3.660.9 at the start and end pressed memory whereas lidocaine did not. Fig. 2B is a of protocol 2 (all P.0.05). Serum lidocaine levels (mg / representative experiment, demonstrating the effects of ml) were 3.260.4 and 2.060.3 for protocol 1 and 3.960.2 quinidine. and 2.960.7 for protocol 2 (all P.0.05). Serum E4031 levels (ng / ml) were 55611.2 and 104615.7 for protocol 1 (P,0.05) and 71621.3 and 84611.6 (P.0.05) for proto-3.2.1. QRS and QT changes col 2. The variation in E4031 concentrations in protocol 1
Measurements were made during atrial and LV pacing. was not expected to affect results, as the cumulative i.v.
No significant effects on QRS duration of atrially paced administration of 100-1000 mg / kg of E4031 has been complexes were observed with any drug. During pacing shown to alter equivalently the ERP, QT and paced QT alone or during pacing in the presence of lidocaine there c intervals [16] . In our experiments the range of cumulative was no significant change in the QT interval. The QT E4031 doses was far smaller, only 170-250 mg / kg. interval during pacing was prolonged by E4031 (P,0.05) and to a lesser extent, quinidine (P,0.05) (Fig. 3) . During 3.2. Protocol 1 recovery periods the QT prolongation induced by E4031 was transiently reduced, while that induced by quinidine This protocol tested the evolution of cardiac memory was reduced persistently. Hence, the effect of quinidine to increase the QT interval during control was reversed well with the evolution of cardiac memory, seen as T during the evolution of memory.
vector displacement (Fig. 5B) .
QRS and QT interval changes 3.2.2. ERP changes
QT intervals during atrial and ventricular pacing were In the absence of drugs, ERP prolongation was seen prolonged in protocol 2 (Table 1) . Lidocaine and E4031 only near the LV inferior wall site of primary ventricular had no effect on the QRS complex, while quinidine pacing. E4031 and quinidine prolonged ERP at all sites.
increased QRS duration significantly. Effects of all drugs Data for the LV inferior site are presented in Fig. 4 . Note on the QT interval differed after 21 days as compared to that despite the suppression of memory by both drugs (Fig. control measurements (Table 1) . Lidocaine lost its effect to 2A) and the alteration in QT interval (Fig. 3) , ERP decrease the QT interval. More importantly, E4031, which prolongation persisted after pacing. Lidocaine had no had prolonged the QT interval initially, prolonged it even effect here (data not shown).
more (during atrial pacing) after 21 days of pacing to induce memory. In contrast, quinidine's effect to prolong 3.3. Protocol 2 the QT interval during atrial and ventricular pacing prior to performing the 21-day protocol was reduced following This protocol tested whether antiarrhythmic drug action induction of memory. was altered in the setting of cardiac memory. At 7 days of ventricular pacing, and in the absence of drugs, T wave 3.3.2. ARI and ERP changes vector displacement was 0.5460.12 mV. At 14 days, At all stimulation sites prior to drug administration, ERP displacement increased to 0.7460.16 mV (P,0.05) and did was prolonged significantly irrespective of whether ARI at not change thereafter (0.7460.07 mV at 21 days). T wave the local site had increased or decreased (Fig. 6A ). This vector amplitude and angle also changed significantly (data suggests a disassociation of pacing effects on ERP and not shown). Given the profound alterations in the T wave repolarization. Moreover, pacing to induce cardiac memory vector in the setting of memory, we measured ARI in increased the dispersion of both ERP and ARI. These protocol 2 to provide information about local changes in actions were not modified by lidocaine (data not shown). repolarization associated with memory and to test the Whereas E4031 significantly and equivalently prolonged effects of drugs. No significant changes occurred in ARI as ERP and ARI before and after memory induction ( 4. Discussion to induce cardiac memory are similar to those we have previously standardized [4, 7, 8, 17] . Based on our prior This study focuses on relationships between a complex observations [8, 17] we had predicted that in the 2-h physiological system (that determining cardiac memory)
protocol there would be a change in the T wave reflecting [2, 5, 7] and three antiarrhythmic drugs: lidocaine, an I evolution of cardiac memory but not in the QRS or QT Na blocker [1,9], E4031, a predominant I blocker [10, 11] , intervals. Both the I blocker, E4031 [10, 11] , and quiniKr Kr 1 and quinidine, which blocks inward Na and repolarizing dine prevented memory from occurring, but lidocaine did anesthetized dogs and in isolated tissues that a drug 21-day protocol saw a small but significant prolongation of blocking I and I (4-aminopyridine) suppresses memory, the QT interval during both ventricular and atrial pacing.
whereas an I blocker, lidocaine, has no effect [8, 18] . Our The ERP was prolonged near the primary left ventricular Na results with E4031 and quinidine are consistent with roles pacing site in the short-term protocol (by 5%), and at all for both I and I in memory induction, and suggest that sites in the long-term protocol (by 7%). That protocol 1
to Kr drugs blocking these currents would suppress memory was associated with a locally prolonged ERP is not and / or prevent it from occurring. surprising, given reports on pacing-induced increases in Long-term pacing to induce steady state cardiac memory ERP in dogs and in human subjects [19] [20] [21] . For example, was associated with an increased QT interval. Given the dogs in complete heart block for 3-7 days, and then paced effect of chronic pacing to increase epicardial and endocarfor 1 h from the LV apex at CL5500 ms in an acute, dial action potential duration [7] , prolongation of the QT open-chest study demonstrated significant QT and ERP interval was not unexpected. The association of memory prolongation [21] . In contrast, dogs in sinus rhythm with reduced I [4] , and reduced Na / K pump current and showed only ERP prolongation [19] . Given the propensity to altered I kinetics (H. Yu and I. Cohen, preliminary of dogs with heart block to develop LV hypertrophy [21] , it Ca,L data) favors a prolongation of repolarization as well. is likely that in the heart blocked dogs hypertrophy evolving in the 3-7 days prior to the acute study con-4.1. Effects of cardiac memory on repolarization and tributed to the repolarization changes. The relationships of the ERP these observations to our own are uncertain, however, as the animals we routinely study are not in heart block and Short-term pacing in protocol 1 to induce memory was have no cardiac hypertrophy [7] . unassociated with QT interval changes. In contrast, the
The discordance between the effects of cardiac memory on ARI and ERP, recorded at various local sites in the interaction. Perhaps most disconcerting from a clinical ventricle, is emphasized in Fig. 6 , as is the change in perspective is the loss of effect of quinidine to prolong antiarrhythmic drug effects seen before and after memory ERP and QT intervals despite the maintenance of steadyoccurred. With memory alone, ARI shortened at a site state plasma levels. This could lead to two problematic (RV) far from the primary pacing electrode, shortened less scenarios: (i) the assumption by a physician of the need for at the LV apex and lengthened at the LV base (earliest higher doses of drug (unless plasma levels are measured) activated of the three). Hence, the previously noted disperand resultant drug toxicity; or (ii) the recurrence of the sion of ARI that characterizes pacing to induce cardiac patient's initial arrhythmia, but with an altered morphology memory [22] occurred in our experiments as well. How-(based on altered voltage-time course of repolarization). ever, despite the changes in ARI, the ERP at each local site
The latter event might mislead a physician to conclude that lengthened. Given the decrease in ARI at the RV site, the the patient is experiencing proarrhythmia rather than a magnitude of change in ERP verges on the generation of recurrence of the initial arrhythmia. post-repolarization refractoriness, whose potential for preOur findings also impact on the interpretation of clinical venting reentrant rhythms has received significant attention electrophysiologic testing of antiarrhythmic drugs, which [23] . The ERP is determined both by the voltage-time has not had the consistent predictive function originally course of repolarization (dependent on inward plateau anticipated. The extent to which pacing during eleccurrents carried by Ca and Na and outward currents carried trophysiologic testing induces memory that accumulates by K) and by the recovery from inactivation of the fast and modifies the actions of certain antiarrhythmic drugs inward sodium current I . Since repolarization changes may contribute to misinterpretation of drug effect. MoreNa are variable depending on the site studied, it is possible over, a drug administered at one time, when a preexisting that pacing to induce cardiac memory has an independent arrhythmia has induced a given expression of memory, effect to prolong recovery from inactivation of I , thereby may act very differently than the same drug administered Na explaining the consistently increased ERP. at another time, when the expression of memory differs. Finally, because memory is associated with altered ion 4.2. Clinical implications channel properties [4] , and because drugs affecting specific ion channels have differing effects based on the extent of If we consider pacing as a surrogate for ventricular expression of memory, we can assume that the binding and arrhythmias, then the observation that pacing to induce unbinding of drugs to their target sites in channels are cardiac memory prolongs ERP more than repolarization altered as memory evolves. This would contribute to the leads to an interesting question; that is, do arrhythmias of complex and apparently inconsistent interactions between unifocal origin and consistent activation pathway have an drug and arrhythmia that are so often seen clinically. 'antiarrhythmic' component that circumscribes their expression? This question awaits testing. It also suggests that ventricular pacing, per se, may provide an antiarrhythmic
